Europe — EMA

Oxaliplatino Teva

Oxaliplatin, the active ingredient in Oxaliplatino Teva, is a platinum‑based chemotherapy agent presented as a unknown strength/unknown form for intravenous use.

Oxaliplatin

Request sourcing

Pack/s

What is Oxaliplatin?

Oxaliplatin, the active ingredient in Oxaliplatino Teva, is a platinum‑based chemotherapy agent presented as a unknown strength/unknown form for intravenous use. It treats colorectal cancer and is used in adult oncology patients. GNH USA supplies Oxaliplatino Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

GNH USA supplies Oxaliplatino Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

What is Oxaliplatin used for?

Oxaliplatin is a chemotherapy drug that acts on the colorectal cancer treatment pathway.

- Metastatic colorectal cancer: Improves overall survival and progression‑free survival in patients with advanced disease. - Adjuvant treatment of colon concern and stage III colon cancer : - - ...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →